Modeling Ketamine Effects on Synaptic Plasticity During the Mismatch Negativity
André Schmidt, Andreea O. Diaconescu, Michael Kometer, Karl Friston, Klaas Ε. Stephan, Franz X. Vollenweider
Cerebral Cortex August 8, 2012 DOI: 10.1093/cercor/bhs238 via OpenAlex
Summary
AI-generated from the abstractUsing dynamic causal modeling and Bayesian model selection on data from a double-blind, placebo-controlled, crossover ketamine study, the authors investigated how the NMDA-receptor antagonist ketamine reduces mismatch negativity (MMN) amplitudes. Guided by a predictive coding framework that unifies adaptation and model adjustment theories, they compared models allowing different expressions of neuronal adaptation and synaptic plasticity. Results replicated that both adaptation and short-term plasticity are necessary for MMN generation. Ketamine significantly affected synaptic plasticity but not adaptation, with a selective effect on the forward connection from left primary auditory cortex to superior temporal gyrus. This model-based estimate of ketamine's effect on synaptic plasticity correlated with ratings of ketamine-induced impairments in cognition and control, suggesting a concrete mechanism linking ketamine effects on MMN to drug-induced psychopathology.
Study at a glance
| Characteristics | Cross-over, double-blind, placebo-controlled design Peer reviewed |
|---|---|
| Intervention | Ketamine |
| Topics | Ketamine Neuroplasticity |
| Keywords | Mismatch negativity Neuroscience Nmda receptor Psychology |
| Citations | 110 |
| Key finding | Ketamine reduces MMN amplitudes by affecting synaptic plasticity, not adaptation, and this effect correlates with drug-induced cognitive impairments. |
Abstract
This paper presents a model-based investigation of mechanisms underlying the reduction of mismatch negativity (MMN) amplitudes under the NMDA-receptor antagonist ketamine. We applied dynamic causal modeling and Bayesian model selection to data from a recent ketamine study of the roving MMN paradigm, using a cross-over, double-blind, placebo-controlled design. Our modeling was guided by a predictive coding framework that unifies contemporary "adaptation" and "model adjustment" MMN theories. Comparing a series of dynamic causal models that allowed for different expressions of neuronal adaptation and synaptic plasticity, we obtained 3 major results: 1) We replicated previous results that both adaptation and short-term plasticity are necessary to explain MMN generation per se; 2) we found significant ketamine effects on synaptic plasticity, but not adaptation, and a selective ketamine effect on the forward connection from left primary auditory cortex to superior temporal gyrus; 3) this model-based estimate of ketamine effects on synaptic plasticity correlated significantly with ratings of ketamine-induced impairments in cognition and control. Our modeling approach thus suggests a concrete mechanism for ketamine effects on MMN that correlates with drug-induced psychopathology. More generally, this demonstrates the potential of modeling for inferring on synaptic physiology, and its pharmacological modulation, from electroencephalography data.